Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-25-000047
Filing Date
2025-08-05
Accepted
2025-08-05 20:43:12
Documents
1
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1754440988.html 4  
1 FORM 4 wk-form4_1754440988.xml 4 19331
  Complete submission text file 0001894562-25-000047.txt   20754
Mailing Address C/O HOOKIPA PHARMA INC. 430 EAST 29TH ST. NEW YORK NY 10016
Business Address
Kelly Michael Aaron (Reporting) CIK: 0001769668 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 251186954

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)